In a 68-week medical study of 1,961 adults living with obesity or excess weight with a related medical problem, adults lost ~35 lbs (or ~15% body weight). People taking placebo in the study (not on medicine) lost an average of 6 lb (or ~2.5% body weight). The average starting weight for both groups was ~232 lbs.*
*Results are from a 68-week medical study of adults with obesity (BMI ≥30) and adults with excess weight (BMI ≥27) who also had weight-related medical problems including high blood pressure or high cholesterol. People with type 2 diabetes were excluded. Both groups received instruction for a reduced-calorie meal plan and increased physical activity. 7% of people taking Wegovy® (92 people) left the medical study due to side effects, compared to 3.1% of people taking placebo (20 people).
• 83% of adults taking Wegovy® lost 5% or more weight, compared to 31% taking placebo
• 66% of adults taking Wegovy® lost 10% or more weight, compared to 12% taking placebo
• 48% of adults taking Wegovy® lost 15% or more weight, compared to 5% taking placebo
About 1 in 3 adults lost 46 lb or more (20% weight loss). This was calculated from ~232 lb starting weight.*
In addition to a reduced-calorie meal plan and increased physical activity, people in this study taking Wegovy® lost more weight vs placebo.
*In a supportive measure, at week 68, at least 20% weight loss was seen in 30% of people taking Wegovy® versus 2% of people taking placebo.
